As of 2026-09-25, the Relative Valuation of Puma Biotechnology Inc (PBYI) is 16.74 USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.82 USD, the upside of Puma Biotechnology Inc based on Relative Valuation is 70.5%.
The range of the Relative Valuation is 14.42 - 19.21 USD.
| Range | Selected | |
| Trailing P/E multiples | 30.1x - 40.1x | 35.1x |
| Forward P/E multiples | 25.2x - 30.8x | 28.0x |
| Fair Price | 14.42 - 19.21 | 16.74 |
| Upside | 46.8% - 95.6% | 70.5% |
| Date | P/E |
| 2026-09-24 | 19.32 |
| 2026-09-23 | 19.37 |
| 2026-09-22 | 20.50 |
| 2026-09-21 | 20.02 |
| 2026-09-18 | 20.04 |
| 2026-09-17 | 19.87 |
| 2026-09-16 | 19.60 |
| 2026-09-15 | 19.31 |
| 2026-09-14 | 19.08 |
| 2026-09-11 | 19.04 |
| 2026-09-10 | 19.14 |
| 2026-09-09 | 18.89 |
| 2026-09-08 | 19.60 |
| 2026-09-04 | 19.93 |
| 2026-09-03 | 19.64 |
| 2026-09-02 | 20.23 |
| 2026-09-01 | 19.52 |
| 2026-08-31 | 19.02 |
| 2026-08-28 | 18.91 |
| 2026-08-27 | 19.29 |
| 2026-08-26 | 19.12 |
| 2026-08-25 | 19.45 |
| 2026-08-24 | 19.04 |
| 2026-08-21 | 19.29 |
| 2026-08-20 | 19.02 |
| 2026-08-19 | 19.81 |
| 2026-08-18 | 19.29 |
| 2026-08-17 | 18.41 |
| 2026-08-14 | 18.43 |
| 2026-08-13 | 18.18 |
| 2026-08-12 | 18.58 |
| 2026-08-11 | 18.31 |
| 2026-08-10 | 18.14 |
| 2026-08-07 | 18.60 |
| 2026-08-06 | 16.95 |
| 2026-08-05 | 16.68 |
| 2026-08-04 | 16.28 |
| 2026-08-03 | 16.05 |
| 2026-07-31 | 16.55 |
| 2026-07-30 | 16.47 |
| 2026-07-29 | 16.30 |
| 2026-07-28 | 16.64 |
| 2026-07-27 | 16.68 |
| 2026-07-24 | 16.66 |
| 2026-07-23 | 16.72 |
| 2026-07-22 | 16.43 |
| 2026-07-21 | 17.91 |
| 2026-07-20 | 17.33 |
| 2026-07-17 | 17.81 |
| 2026-07-16 | 17.53 |